Literature DB >> 6877781

The management of central retinal vein occlusion.

E M Kohner, L Laatikainen, J Oughton.   

Abstract

Central retinal vein occlusion is the result of outflow obstruction and is associated with a variety of medical conditions, mainly affecting the vascular system. Treatment of the coexistent medical conditions has no beneficial effect on visual outcome. Outflow obstruction has been treated by fibrinolytic agents and anticoagulants, hemodilution, and photocoagulation. None of these treatments were of value in improving or maintaining vision. Photocoagulation prevents neovascular complications in ischemic central retinal vein occlusion.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6877781     DOI: 10.1016/s0161-6420(83)34527-9

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  11 in total

1.  Treatment of recent onset central retinal vein occlusion with intravitreal tissue plasminogen activator: a pilot study.

Authors:  A Glacet-Bernard; D Kuhn; A K Vine; H Oubraham; G Coscas; G Soubrane
Journal:  Br J Ophthalmol       Date:  2000-06       Impact factor: 4.638

2.  Role of vascular endothelial growth factor in the breakdown of the blood-aqueous barrier after retinal laser photocoagulation in pigmented rabbits.

Authors:  Muh-Shy Chen; Ching-Chung Chang; Chang-Ping Lin; Peng-Chen Wang; Li-Rong Lin; Ping-Kang Hou; Tzyy-Chang Ho
Journal:  J Ocul Pharmacol Ther       Date:  2011-10-19       Impact factor: 2.671

Review 3.  Central retinal vein occlusion: what's the story?

Authors:  T H Williamson
Journal:  Br J Ophthalmol       Date:  1997-08       Impact factor: 4.638

4.  A rare cause of visual loss in AIDS patients: central retinal vein occlusion.

Authors:  Y Ismail; P M Nemechek; E L Arsura
Journal:  Br J Ophthalmol       Date:  1993-09       Impact factor: 4.638

Review 5.  Parasympathetic denervation of the ciliary muscle following retinal photocoagulation.

Authors:  P L Kaufman
Journal:  Trans Am Ophthalmol Soc       Date:  1990

6.  Medical conditions underlying retinal vein occlusion in patients with glaucoma or ocular hypertension.

Authors:  M D Cole; P M Dodson; S Hendeles
Journal:  Br J Ophthalmol       Date:  1989-09       Impact factor: 4.638

7.  Hemodilution therapy using automated erythrocytapheresis in central retinal vein occlusion: results of a multicenter randomized controlled study.

Authors:  Agnès Glacet-Bernard; Marielle Atassi; Christine Fardeau; Jean-Paul Romanet; Matthieu Tonini; John Conrath; Philippe Denis; Martine Mauget-Faÿsse; Gabriel Coscas; Gisèle Soubrane; Eric Souied
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-10-17       Impact factor: 3.117

Review 8.  The therapeutic potential of intraocular depot steroid systems: developments aimed at prolonging duration of efficacy.

Authors:  Martin M Nentwich; Michael W Ulbig
Journal:  Dtsch Arztebl Int       Date:  2012-09-14       Impact factor: 5.594

9.  Medical conditions underlying recurrence of retinal vein occlusion.

Authors:  P M Dodson; A J Kubicki; K G Taylor; E E Kritzinger
Journal:  Br J Ophthalmol       Date:  1985-07       Impact factor: 4.638

10.  A randomised prospective study on treatment of central retinal vein occlusion by isovolaemic haemodilution and photocoagulation.

Authors:  L L Hansen; P Danisevskis; H R Arntz; G Hövener; M Wiederholt
Journal:  Br J Ophthalmol       Date:  1985-02       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.